The data, presented at the San Antonio Breast Cancer Symposium, come from 184 patients with advanced HER2-positive breast cancer who received ...
News
- SABCS: AstraZeneca, Daiichi's ADC keeps breast cancer at bay for 16 months
- Hispanic Chamber's Erika Gonzalez Wants to Keep Small Businesses Healthy
Dr. Erika Gonzalez joined the San Antonio Hispanic Chamber of Commerce in ... involved in the group's efforts related to health care and biosciences.
- Phoenix Biotechnology Announces Completion of Private Placement
SAN ANTONIO--(BUSINESS WIRE)--Phoenix Biotechnology, Inc. (“Phoenix” or the “Company” www.phoenixbiotechnology.com) today announced ...
- Biothera Pharmaceuticals Presents Updated Phase 2 Data for Chemo-refractory Triple Negative ...
... Chemo-refractory Triple Negative Breast Cancer Patients at San Antonio Breast Cancer Symposium .... About Biothera Pharmaceuticals, Inc.Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime ...
- New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium
New Menarini CELLSEARCH Studies to be Presented at San Antonio ... biotechnology and diagnostics company headquartered in Florence, Italy, ...